Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piero Olliaro

Showing results (1-10 of 240) with videos related to

Pageof 24
Sort By:
Clinical Evidence|September 17, 2002
Congenital toxoplasmosisPiero Olliaro
Clinical Evidence|May 4, 2005
Congenital toxoplasmosisPiero Olliaro
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 21, 2005
Drug resistance hampers our capacity to roll back malariaPiero Olliaro
Tropical Medicine & International Health : TM & IH|March 27, 2009
Management of fever and malaria - policy and practicePiero Olliaro
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2008
Disease and drug interactions: treating malaria with artesunate plus amodiaquine in patients also receiving treatment for concomitant HIV infectionPiero Olliaro
The Lancet. Infectious Diseases|February 20, 2021
What does 95% COVID-19 vaccine efficacy really mean?Piero Olliaro
Clinical Evidence|February 27, 2003
Congenital toxoplasmosisPiero Olliaro
Clinical Evidence|September 12, 2003
Congenital toxoplasmosisPiero Olliaro
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 21, 2008
Editorial commentary: mortality associated with severe Plasmodium falciparum malaria increases with agePiero Olliaro
BMJ (Clinical Research Ed.)|May 25, 2022
Waking up to monkeypoxEmmanuel Nakoune, Piero Olliaro
Pageof 24

Showing results (1-10 of 240) with videos related to

Sort By:
Pageof 24
Clinical Evidence|September 17, 2002
Congenital toxoplasmosisPiero Olliaro
Clinical Evidence|May 4, 2005
Congenital toxoplasmosisPiero Olliaro
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 21, 2005
Drug resistance hampers our capacity to roll back malariaPiero Olliaro
Tropical Medicine & International Health : TM & IH|March 27, 2009
Management of fever and malaria - policy and practicePiero Olliaro
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2008
Disease and drug interactions: treating malaria with artesunate plus amodiaquine in patients also receiving treatment for concomitant HIV infectionPiero Olliaro
The Lancet. Infectious Diseases|February 20, 2021
What does 95% COVID-19 vaccine efficacy really mean?Piero Olliaro
Clinical Evidence|February 27, 2003
Congenital toxoplasmosisPiero Olliaro
Clinical Evidence|September 12, 2003
Congenital toxoplasmosisPiero Olliaro
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 21, 2008
Editorial commentary: mortality associated with severe Plasmodium falciparum malaria increases with agePiero Olliaro
BMJ (Clinical Research Ed.)|May 25, 2022
Waking up to monkeypoxEmmanuel Nakoune, Piero Olliaro
Pageof 24